Spots Global Cancer Trial Database for paclitaxel, mitotic inhibitor; intravenous
Every month we try and update this database with for paclitaxel, mitotic inhibitor; intravenous cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | NCT01649336 | Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | MEK162, MEK inh... Paclitaxel, mit... | 18 Years - | Array BioPharma | |
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | NCT01649336 | Epithelial Ovar... Fallopian Tube ... Peritoneal Canc... | MEK162, MEK inh... Paclitaxel, mit... | 18 Years - | Array BioPharma |